Patrick Wareing
LightNews LightNews
patrickwareing.bsky.social
Patrick Wareing
@patrickwareing.bsky.social
84 followers 490 following 250 posts
Weekly news to your inbox every Monday morning 👉https://patrickwareing.kit.com/a70ed18837
Posts Replies Media Videos
Pinned
patrickwareing.bsky.social
Patrick Wareing @patrickwareing.bsky.social · Jul 24
Too much news? Not enough time?

Stay up to date with the latest B2B life science news

patrickwareing.kit.com/email-signup
Life Science News to Your Inbox
Get a weekly summary of the past week's life science, pharma and biotech news
patrickwareing.kit.com
patrickwareing.bsky.social
AstraZeneca Acquires SixPeaks Bio for $170 Million Upfront

patrickwareing.com/news/astraze...
AstraZeneca Acquires SixPeaks Bio for $170 Million Upfront - Patrick Wareing
AstraZeneca has exercised its option to purchase SixPeaks Bio, a Swiss-based obesity startup, for an upfront payment of $170 million, with the total deal
patrickwareing.com
November 13, 2025 at 10:30 AM
patrickwareing.bsky.social
Pfizer Wins $10 Billion Bidding War for Metsera as Novo Nordisk Exits

patrickwareing.com/news/pfizer-...
Pfizer Wins $10 Billion Bidding War for Metsera as Novo Nordisk Exits - Patrick Wareing
After a fierce and public bidding war, Pfizer has emerged victorious in acquiring Metsera, a biotech focused on innovative obesity treatments, for more than
patrickwareing.com
November 12, 2025 at 5:03 PM
patrickwareing.bsky.social
Ionis Pharmaceuticals Announces “Game Changing” Triglyceride-Lowering Drug with Strong Phase III Results and Plans FDA Submission

patrickwareing.com/news/ionis-p...
Ionis Pharmaceuticals Announces "Game Changing" Triglyceride-Lowering Drug with Strong Phase III Results and Plans FDA Submission - Patrick Wareing
Ionis Pharmaceuticals unveiled groundbreaking Phase III trial data for olezarsen (formerly AKCEA-APOCIII-LRx), positioning the drug as a potential game
patrickwareing.com
November 12, 2025 at 2:15 PM
patrickwareing.bsky.social
Eli Lilly Acquires Eye Gene Therapy from MeiraGTx to Treat Ultra-Rare Childhood Blindness

patrickwareing.com/news/eli-lil...
Eli Lilly Acquires Eye Gene Therapy from MeiraGTx to Treat Ultra-Rare Childhood Blindness - Patrick Wareing
Eli Lilly announced a strategic licensing agreement with MeiraGTx granting it worldwide exclusive rights to develop and commercialize AAV-AIPL1, a gene
patrickwareing.com
November 12, 2025 at 11:01 AM
patrickwareing.bsky.social
Gilead’s Trodelvy Fails to Meet Primary Endpoint in Key Phase III Breast Cancer Trial

patrickwareing.com/science-news/
Latest Pharmaceutical, Life Science & Biotechnology News
Stay updated with the latest developments in pharmaceuticals, life sciences, and biotechnology. Expert insights & news curated by Patrick Wareing.
patrickwareing.com
November 11, 2025 at 5:01 PM
patrickwareing.bsky.social
Propanc Biopharma Secures Up to $100 Million to Fund Crypto Treasury and Accelerate Cancer Therapy Pipeline

patrickwareing.com/news/propanc...
Propanc Biopharma Secures Up to $100 Million to Fund Crypto Treasury and Accelerate Cancer Therapy Pipeline - Patrick Wareing
Propanc Biopharma, an innovative Australia-based biotechnology company, announced a strategic financing agreement to secure up to $100 million in funding
patrickwareing.com
November 11, 2025 at 2:15 PM
patrickwareing.bsky.social
Iambic Therapeutics Secures Over $100 Million to Advance AI-Driven Drug Discovery and Clinical Programs

patrickwareing.com/news/iambic-...
Iambic Therapeutics Secures Over $100 Million to Advance AI-Driven Drug Discovery and Clinical Programs - Patrick Wareing
Iambic Therapeutics, a clinical-stage biotech combining artificial intelligence with drug discovery science, announced a successful oversubscribed financing
patrickwareing.com
November 11, 2025 at 11:15 AM
patrickwareing.bsky.social
Caribou Biosciences Presents Promising Early Results for ‘Off-the-Shelf’ Cancer Cell Therapy

patrickwareing.com/news/caribou...
Caribou Biosciences Presents Promising Early Results for ‘Off-the-Shelf’ Cancer Cell Therapy - Patrick Wareing
Caribou Biosciences announced encouraging early clinical data for its allogeneic “off-the-shelf” CAR-T cell therapy, vispacabtagene regedleucel (vispa-cel),
patrickwareing.com
November 10, 2025 at 5:03 PM
patrickwareing.bsky.social
Neok Bio Launches with $75 Million Series A to Develop Dual-Targeting Antibody-Drug Conjugates for Cancer

patrickwareing.com/news/neok-bi...
Neok Bio Launches with $75 Million Series A to Develop Dual-Targeting Antibody-Drug Conjugates for Cancer - Patrick Wareing
Neok Bio, a biotechnology startup based in Palo Alto, California, has officially launched with a $75 million Series A financing round, led by principal
patrickwareing.com
November 10, 2025 at 2:45 PM
patrickwareing.bsky.social
Evommune Secures $150M in IPO Amid Federal Government Shutdown

patrickwareing.com/news/evommun...
Evommune Secures $150M in IPO Amid Federal Government Shutdown - Patrick Wareing
Evommune, a biotechnology company based in Palo Alto, California, has completed its initial public offering (IPO), raising $150 million despite ongoing US
patrickwareing.com
November 10, 2025 at 11:45 AM
patrickwareing.bsky.social
Accipiter Biosciences Emerges from Stealth with $12.7 Million Seed Funding for de novo Protein Therapies

patrickwareing.com/news/accipit...
Accipiter Biosciences Emerges from Stealth with $12.7 Million Seed Funding for de novo Protein Therapies - Patrick Wareing
Accipiter Biosciences officially launched from stealth mode with $12.7 million in seed financing to accelerate the development of its pioneering de novo
patrickwareing.com
November 7, 2025 at 5:15 PM
patrickwareing.bsky.social
Italian Biotech AAVantgarde Raises $141 Million Series B to Advance Eye Gene Therapy Pipeline

patrickwareing.com/news/italian...
Italian Biotech AAVantgarde Raises $141 Million Series B to Advance Eye Gene Therapy Pipeline - Patrick Wareing
AAVantgarde Bio, an Italian clinical-stage biotech specializing in gene therapies for inherited retinal diseases (IRDs), announced the successful closing of a
patrickwareing.com
November 7, 2025 at 2:15 PM
patrickwareing.bsky.social
Biohaven Cuts R&D Spending by 60% Following FDA Rejection of Vyglxia for Rare Disease

patrickwareing.com/news/biohave...
Biohaven Cuts R&D Spending by 60% Following FDA Rejection of Vyglxia for Rare Disease - Patrick Wareing
Biohaven announced a substantial cutback in research and development spending following the U.S. Food and Drug Administration’s refusal to approve Vyglxia
patrickwareing.com
November 7, 2025 at 11:00 AM
patrickwareing.bsky.social
Billionaire-Backed Arena BioWorks Shuts Down After $500 Million Launch Effort

patrickwareing.com/news/billion...
Billionaire-Backed Arena BioWorks Shuts Down After $500 Million Launch Effort - Patrick Wareing
Arena BioWorks, a high-profile biotech research institute based in Cambridge, is closing its doors after less than two years of operation despite initially
patrickwareing.com
November 6, 2025 at 5:15 PM
patrickwareing.bsky.social
AstraZeneca Boosts Investment in Chinese Inhalants Facility, Total Funding Hits $886 Million

patrickwareing.com/news/astraze...
AstraZeneca Boosts Investment in Chinese Inhalants Facility, Total Funding Hits $886 Million - Patrick Wareing
AstraZeneca has increased its commitment to its inhalants manufacturing operations in Qingdao, eastern China, by injecting an additional $136 million,
patrickwareing.com
November 6, 2025 at 2:45 PM
patrickwareing.bsky.social
Braveheart Bio Raises $185 Million Series A to Develop Hypertrophic Cardiomyopathy Therapy

patrickwareing.com/news/bravehe...
Braveheart Bio Raises $185 Million Series A to Develop Hypertrophic Cardiomyopathy Therapy - Patrick Wareing
Braveheart Bio, a newly established biotech company focused on hypertrophic cardiomyopathy (HCM), announced its debut with a $185 million Series A funding
patrickwareing.com
November 6, 2025 at 11:15 AM
patrickwareing.bsky.social
Celltrion Signs $744 Million Deal for Two Preclinical Autoimmune Drug Candidates

patrickwareing.com/news/celltri...
Celltrion Signs $744 Million Deal for Two Preclinical Autoimmune Drug Candidates - Patrick Wareing
South Korean biopharmaceutical company Celltrion has expanded its pipeline beyond biosimilars by signing a licensing deal worth up to $744 million for two
patrickwareing.com
November 5, 2025 at 5:04 PM
patrickwareing.bsky.social
Boehringer Ingelheim Inks $570 Million Global License Deal with CDR-Life for Autoimmune Antibody

patrickwareing.com/news/boehrin...
Boehringer Ingelheim Inks $570 Million Global License Deal with CDR-Life for Autoimmune Antibody - Patrick Wareing
Boehringer Ingelheim has expanded its autoimmune therapy pipeline through a strategic alliance with CDR-Life, acquiring exclusive global rights to develop and
patrickwareing.com
November 5, 2025 at 2:45 PM
patrickwareing.bsky.social
Merck Secures $700 Million From Blackstone, Invests $150 Million to Regain Control of Early-Phase Asset

patrickwareing.com/news/merck-s...
Merck Secures $700 Million From Blackstone, Invests $150 Million to Regain Control of Early-Phase Asset - Patrick Wareing
Merck announced a significant financial and strategic partnership with Blackstone Life Sciences, securing $700 million to co-fund the late-stage development
patrickwareing.com
November 5, 2025 at 11:15 AM
patrickwareing.bsky.social
Bayer Gains FDA Approval for Lynkuet, Sets Stage for Market Battle with Astellas Pharma

patrickwareing.com/news/bayer-g...
Bayer Gains FDA Approval for Lynkuet, Sets Stage for Market Battle with Astellas Pharma - Patrick Wareing
Bayer has secured FDA approval for Lynkuet (generic name elinzanetant), a once-daily oral capsule designed to relieve moderate to severe vasomotor symptoms
patrickwareing.com
November 4, 2025 at 5:04 PM
patrickwareing.bsky.social
Eli Lilly to Invest $3 Billion in Netherlands Facility for Oral Obesity Drug Production

patrickwareing.com/news/eli-lil...
Eli Lilly to Invest $3 Billion in Netherlands Facility for Oral Obesity Drug Production - Patrick Wareing
Eli Lilly plans a major expansion of its European manufacturing footprint with a $3 billion investment in a state-of-the-art production facility to be located
patrickwareing.com
November 4, 2025 at 2:45 PM
patrickwareing.bsky.social
AstraZeneca Secures Shareholder Approval for NYSE Listing, Facilitating US Market Pivot

patrickwareing.com/news/astraze...
AstraZeneca Secures Shareholder Approval for NYSE Listing, Facilitating US Market Pivot - Patrick Wareing
AstraZeneca announced on November 3, 2025, that its shareholders have approved the company’s proposal for a direct listing on the New York Stock Exchange
patrickwareing.com
November 4, 2025 at 11:45 AM
patrickwareing.bsky.social
Nanobiotix Secures $71 Million in Royalty Monetization Deal with HealthCare Royalty

patrickwareing.com/news/nanobio...
Nanobiotix Secures $71 Million in Royalty Monetization Deal with HealthCare Royalty - Patrick Wareing
Nanobiotix disclosed a major financial partnership with HealthCare Royalty to monetize royalties from its flagship oncology asset JNJ-1900 (NBTXR3), a
patrickwareing.com
November 3, 2025 at 5:02 PM
patrickwareing.bsky.social
Otsuka Signs $420 Million Deal for Asia Rights to 4D Molecular Therapeutics’ Gene Therapy

patrickwareing.com/news/otsuka-...
Otsuka Signs $420 Million Deal for Asia Rights to 4D Molecular Therapeutics’ Gene Therapy - Patrick Wareing
4D Molecular Therapeutics (4DMT) has entered a strategic partnership with Japan’s Otsuka Pharmaceuticals to develop and commercialize 4D-150, a gene therapy
patrickwareing.com
November 3, 2025 at 2:15 PM
patrickwareing.bsky.social
Thermo Fisher Scientific Acquires Clario for $9 Billion to Expand Clinical Trial Technology

patrickwareing.com/news/thermo-...
Thermo Fisher Scientific Acquires Clario for $9 Billion to Expand Clinical Trial Technology - Patrick Wareing
Thermo Fisher Scientific, a global leader in life sciences and laboratory products, has agreed to acquire Clario Holdings, a premier clinical trial technology
patrickwareing.com
November 3, 2025 at 11:30 AM